参考文献:[1] Saá Ibusquiza P, Herrera J.J.R, Cabo M.L. Resistance to benzalkonium chloride, peracetic acic and nisin during formation of mature biofilms by Listeria monocytogenes. Food Microbiol. 2011, 28:418-425.[2] Carlton R M, Noordman W H, Biswas B, et al. Bacteriophage P100 for control of Listeria monocytogenes in foods: genome sequence, bioinformatic analyses, oral toxicity study, and application. Regul Toxicol Pharmacol, 2005, 43(3): 301-312.[3] Guenther S, Huwyler D, Richard S, et al. Virulent bacteriphage for efficient biocontrol of Listeria monocytogenes in ready-to-eat foods. Appl Environ Microbiol, 2009, 75(1): 93-100.[4] 张 辉, 王 冉, 包红朵. 李斯特菌噬菌体的分离鉴定及其裂解特性. 食品科学. 2012, 33(7): 228-232.[5] 张 辉,焦新安,潘志明, 等. 口服重组沙门菌诱导的免疫应答动态分析. 中国预防兽医学报. 2007, 29(5):372-375.[6] Leverentz B, Conway W.S, Camp M.J, et al. Biocontrol of Listeria monocytogenes on fresh-cut produce by treatment with lytic bacteriophages and a bacteriocin. Appl Environ Microbiol. 2003, 69, 4519–4526.[7] Leverentz B, Conway W.S, Janisiewicz W, et al. Optimizing concentration and timing of a phage spray application to reduce Listeria monocytogenes on honeydew melon tissue. J Food Prot. 2004, 67:1682–1686.[8] Mai V, Ukhanova M, Visone L, et al. Bacteriophage administration reduces the concentration of Listeria monocytogenes in the gastrointestinal tract and its translocation to spleen and liver in experimentally infected mice. Int J Microbiol. 2010, 2010:624-234. [9] Biswas B, Adhya S, Washart P, et al. Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcusfaecium. Infect Immunol. 2002, 70: 204–210.[10] Cerveny K.E, DePaola A, Duckworth H, et al. Phage therapy of local and systemic disease caused by Vibrio vulniWcus in irondextran-treated mice. Infect Immunol. 2002, 70: 6251–6262.[11] Chibani-Chennou W.S, Sidoti J, Bruttin A, et al. In vitro and in vivo bacteriolytic activities of Escherichia coli phages: implications for phage therapy. Antimicrob Agents Chemother. 2004b, 48: 2558–2569.[12] Bruttin A, Brussow H. Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy. Antimicrob Agents Chemother. 2005, 49: 2874–2878. |